Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-039272

Chief Commercial Officer sold 25,000 shares at an average $20.00 ($500,115)

  • Chief Commercial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Maduck Sean Chief Commercial Officer 2021-10-01 Option exercise +24,363 $3.29 $80,154 64,387 D
Maduck Sean Chief Commercial Officer 2021-10-01 Sale −24,363 $20.00 $487,375 40,024 D
Maduck Sean Chief Commercial Officer 2021-10-05 Option exercise +637 $3.29 $2,096 40,661 D
Maduck Sean Chief Commercial Officer 2021-10-05 Sale −637 $20.00 $12,740 40,024 D
Derivatives
Maduck Sean Chief Commercial Officer 2021-10-01 Option exercise · Stock Option (Right to Buy) −24,363 123,239 D
Maduck Sean Chief Commercial Officer 2021-10-05 Option exercise · Stock Option (Right to Buy) −637 122,602 D
Open-market sales · 25,000 sh · avg $20.00 · $500,115
Loading xslF345X03/doc4.xml…